+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Methotrexate"

Dermatomycoses Market Report 2025 - Product Thumbnail Image

Dermatomycoses Market Report 2025

  • Report
  • May 2025
  • 175 Pages
  • Global
From
Prescription Orthopedic Drugs Global Market Report 2025 - Product Thumbnail Image

Prescription Orthopedic Drugs Global Market Report 2025

  • Report
  • January 2025
  • 175 Pages
  • Global
From
From
Uveitis Drugs - Global Strategic Business Report - Product Thumbnail Image

Uveitis Drugs - Global Strategic Business Report

  • Report
  • June 2025
  • 413 Pages
  • Global
From
Systemic Lupus Erythematosus Treatment Market Report 2025 - Product Thumbnail Image

Systemic Lupus Erythematosus Treatment Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Systemic Lupus Erythematosus Drugs Market 2025-2033 - Product Thumbnail Image

Systemic Lupus Erythematosus Drugs Market 2025-2033

  • Report
  • March 2025
  • 144 Pages
  • Global
From
Psoriasis Market Report 2025 - Product Thumbnail Image

Psoriasis Market Report 2025

  • Report
  • April 2025
  • 175 Pages
  • Global
From
Severe Psoriasis Epidemiology Forecast 2025-2034 - Product Thumbnail Image

Severe Psoriasis Epidemiology Forecast 2025-2034

  • Report
  • May 2025
  • 150 Pages
  • Global
From
Scleroderma - Pipeline Insight, 2025 - Product Thumbnail Image

Scleroderma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 180 Pages
  • Global
From
From
Psoriatic Arthritis - Pipeline Insight, 2025 - Product Thumbnail Image

Psoriatic Arthritis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Graft Versus Host Disease (GvHD) - Pipeline Insight, 2025 - Product Thumbnail Image

Graft Versus Host Disease (GvHD) - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 180 Pages
  • Global
From
From
From
Moderate To Severe Atopic Dermatitis - Pipeline Insight, 2025 - Product Thumbnail Image

Moderate To Severe Atopic Dermatitis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Rheumatoid Arthritis - Pipeline Insight, 2025 - Product Thumbnail Image

Rheumatoid Arthritis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 180 Pages
  • Global
From
Metastatic Urothelial Carcinoma- Pipeline Insight, 2025 - Product Thumbnail Image

Metastatic Urothelial Carcinoma- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 150 Pages
  • Global
From
Still's Disease- Pipeline Insight, 2025 - Product Thumbnail Image

Still's Disease- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Dermatomyositis - Pipeline Insight, 2025 - Product Thumbnail Image

Dermatomyositis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Juvenile Rheumatoid Arthritis - Pipeline Insight, 2025 - Product Thumbnail Image

Juvenile Rheumatoid Arthritis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Loading Indicator

Methotrexate is a drug used to treat immune disorders, such as rheumatoid arthritis, psoriasis, and Crohn's disease. It works by blocking the action of an enzyme involved in the production of certain proteins that are necessary for the growth and development of cells. It is also used to treat certain types of cancer. Methotrexate is available in both oral and injectable forms. Methotrexate is a widely used drug in the treatment of immune disorders. It is generally well tolerated and has been shown to be effective in reducing symptoms and improving quality of life. It is also used in combination with other drugs to treat more severe cases of immune disorders. The market for Methotrexate is highly competitive, with many companies offering different formulations of the drug. Some of the major players in the market include Pfizer, Merck, Novartis, and AbbVie. Show Less Read more